Pulmonary surfactant in cystic fibrosis

Cystic fibrosis (CF) leads to a chronic inflammation of the airways with significant air flow limitations developing early in the course of the disease. As a well-functioning pulmonary surfactant is necessary to keep the alveoli and the small conducting airways open during expiration, we hypothesized that the biochemical and biophysical properties of surfactant may be impaired in CF. Bronchoalveolar lavage fluid obtained during a clinically stable period was analysed from 20 CF patients (5.9-20 yrs) and 17 healthy children and adults. CF patients had significantly elevated total and polymorphonuclear neutrophil cell counts, whereas the concentrations of total protein and phospholipids did not differ from controls. The percentage of surface active phospholipids, phosphatidylcholine and phosphatidylglycerol, and the concentration of surfactant protein A were significantly reduced in CF patients. Surfactant protein B was unchanged. Although the relative proportion of large aggregates was higher in CF, their surface active properties were inferior, as assessed in the pulsating bubble surfactometer. Because the capacity of CF lavage fractions to inhibit surfactant function was the same as that of controls, impaired minimal surface tension was more likely to be due to the biochemical alterations detected, than to inhibition of a well-functioning surfactant. The impaired pulmonary surfactant system in clinically stable patients with cystic fibrosis is in agreement with the view that surfactant dysfunction may contribute to lung disease in cystic fibrosis.

This article has been cited by other articles:

				H. Tavana, D. Huh, J. B. Grotberg, and S. Takayama Microfluidics, Lung Surfactant, and Respiratory Disorders Lab Med, April 1, 2009; 40(4): 203 - 209. [Full Text] [PDF]

				J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955. [Abstract] [Full Text] [PDF]

				V. Starosta, F. Ratjen, E. Rietschel, K. Paul, and M. Griese Anti-inflammatory cytokines in cystic fibrosis lung disease Eur. Respir. J., September 1, 2006; 28(3): 581 - 587. [Abstract] [Full Text] [PDF]

				V. Starosta, E. Rietschel, K. Paul, U. Baumann, and M. Griese Oxidative Changes of Bronchoalveolar Proteins in Cystic Fibrosis. Chest, February 1, 2006; 129(2): 431 - 437. [Abstract] [Full Text] [PDF]

				A. L. Beatty, J. L. Malloy, and J. R. Wright Pseudomonas aeruginosa Degrades Pulmonary Surfactant and Increases Conversion In Vitro Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 128 - 134. [Abstract] [Full Text] [PDF]

				J. L. Malloy, R. A. W. Veldhuizen, B. A. Thibodeaux, R. J. O'Callaghan, and J. R. Wright Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L409 - L418. [Abstract] [Full Text] [PDF]

				A. N. Mikerov, T. M. Umstead, W. Huang, W. Liu, D. S. Phelps, and J. Floros SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L150 - L158. [Abstract] [Full Text] [PDF]

				A. Braun, M. Steinecker, S. Schumacher, and M. Griese Surfactant function in children with chronic airway inflammation J Appl Physiol, December 1, 2004; 97(6): 2160 - 2165. [Abstract] [Full Text] [PDF]

				M. Griese, R. Essl, R. Schmidt, E. Rietschel, F. Ratjen, M. Ballmann, K. Paul, and for the BEAT Study Group Pulmonary Surfactant, Lung Function, and Endobronchial Inflammation in Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 1000 - 1005. [Abstract] [Full Text] [PDF]

				A. M. LeVine, J. Elliott, J. A. Whitsett, A. Srikiatkhachorn, E. Crouch, N. DeSilva, and T. Korfhagen Surfactant Protein-D Enhances Phagocytosis and Pulmonary Clearance of Respiratory Syncytial Virus Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 193 - 199. [Abstract] [Full Text] [PDF]

				J. F. Alcorn and J. R. Wright Degradation of Pulmonary Surfactant Protein D by Pseudomonas aeruginosa Elastase Abrogates Innate Immune Function J. Biol. Chem., July 16, 2004; 279(29): 30871 - 30879. [Abstract] [Full Text] [PDF]

				F. Brasch, M. Griese, M. Tredano, G. Johnen, M. Ochs, C. Rieger, S. Mulugeta, K.M. Muller, M. Bahuau, and M.F. Beers Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Eur. Respir. J., July 1, 2004; 24(1): 30 - 39. [Abstract] [Full Text] [PDF]

				F Rubio, J Cooley, F J Accurso, and E Remold-O'Donnell Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease Thorax, April 1, 2004; 59(4): 318 - 323. [Abstract] [Full Text] [PDF]

				T. L. Noah, P. C. Murphy, J. J. Alink, M. W. Leigh, W. M. Hull, M. T. Stahlman, and J. A. Whitsett Bronchoalveolar Lavage Fluid Surfactant Protein-A and Surfactant Protein-D Are Inversely Related to Inflammation in Early Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 685 - 691. [Abstract] [Full Text] [PDF]

				W. I. Mariencheck, J. F. Alcorn, S. M. Palmer, and J. R. Wright Pseudomonas aeruginosa Elastase Degrades Surfactant Proteins A and D Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 528 - 537. [Abstract] [Full Text] [PDF]

				P. Bufler, B. Schmidt, D. Schikor, A. Bauernfeind, E. C. Crouch, and M. Griese Surfactant Protein A and D Differently Regulate the Immune Response to Nonmucoid Pseudomonas aeruginosa and Its Lipopolysaccharide Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 249 - 256. [Abstract] [Full Text] [PDF]

				M. Griese, M. Neumann, T. von Bredow, R. Schmidt, and F. Ratjen Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates Eur. Respir. J., November 1, 2002; 20(5): 1284 - 1291. [Abstract] [Full Text] [PDF]

				M. Griese, N. Maderlechner, P. Ahrens, and R. Kitz Surfactant Proteins A and D in Children with Pulmonary Disease due to Gastroesophageal Reflux Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1546 - 1550. [Abstract] [Full Text] [PDF]

				T. R. Korfhagen Surfactant Protein A (SP-A)-Mediated Bacterial Clearance . SP-A and Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 668 - 672. [Full Text] [PDF]

				K. R. Khubchandani, R. E. Oberley, and J. M. Snyder Effects of Surfactant Protein A and NaCl Concentration on the Uptake of Pseudomonas aeruginosa by THP-1 Cells Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 699 - 706. [Abstract] [Full Text] [PDF]

				M. Griese, A. Baatz, J. Beck, and B. Deubzer Uptake of a natural surfactant and increased delivery of small organic anions into type II pneumocytes Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L144 - L154. [Abstract] [Full Text] [PDF]

				C. von Bredow, P. Birrer, and M. Griese Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis Eur. Respir. J., April 1, 2001; 17(4): 716 - 722. [Abstract] [Full Text] [PDF]

				K. C. Meyer, A. Sharma, R. Brown, M. Weatherly, F. R. Moya, J. Lewandoski, and J. J. Zimmerman Function and Composition of Pulmonary Surfactant and Surfactant-Derived Fatty Acid Profiles Are Altered in Young Adults With Cystic Fibrosis Chest, July 1, 2000; 118(1): 164 - 174. [Abstract] [Full Text] [PDF]

				R. Banerjee and R. R. Puniyani Exogenous Surfactant Therapy and Mucus Rheology in Chronic Obstructive Airway Diseases J Biomater Appl, January 1, 2000; 14(3): 243 - 272. [Abstract] [PDF]

				C. I. Restrepo, Q. Dong, J. Savov, W. I. Mariencheck, and J. R. Wright Surfactant Protein D Stimulates Phagocytosis of Pseudomonas aeruginosa by Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 576 - 585. [Abstract] [Full Text]

				W. I. Mariencheck, J. Savov, Q. Dong, M. J. Tino, and J. R. Wright Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L777 - L786. [Abstract] [Full Text] [PDF]

				M. Griese, C. Wilnhammer, S. Jansen, and C. Rinker CARDIOPULMONARY BYPASS REDUCES PULMONARY SURFACTANT ACTIVITY IN INFANTS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 237 - 244. [Abstract] [Full Text] [PDF]

				C. HERMANS and A. BERNARD Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678. [Full Text]

				A. D. Postle, A. Mander, K. B. M. Reid, J.-Y. Wang, S. M. Wright, M. Moustaki, and J. O. Warner Deficient Hydrophilic Lung Surfactant Proteins A and D with Normal Surfactant Phospholipid Molecular Species in Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 90 - 98. [Abstract] [Full Text]

				A. M. LeVine, K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen Surfactant Protein-A-Deficient Mice Are Susceptible to Pseudomonas aeruginosa Infection Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 700 - 708. [Abstract] [Full Text]